Principal Investigator
Ki Chung
Memorial Sloan Kettering Cancer Center
Total Trials
1
As PI
1
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
MIXED(2)
BIOLOGICAL(1)
pharmacological study
1 trial
phase_2
national-cancer-institute-ncilaboratory biomarker analysis
1 trial
phase_2
national-cancer-institute-ncioblimersen sodium
1 trial
phase_2
national-cancer-institute-nci3 unique interventions2 categories
Analytics
Trial Phases
Phase 21
Trial Status
Completed1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
Oblimersen in Treating Patients With Merkel Cell Carcinoma
Recurrent Neuroendocrine Carcinoma of the SkinStage I Neuroendocrine Carcinoma of the SkinStage II Neuroendocrine Carcinoma of the Skin+2 more
Principalinvestigator
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Memorial Sloan Kettering Cancer Center
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
2 similar investigators found
Agustin Garcia
University of Southern California
4 trials
Shared therapeutic areas:
Recurrent Neuroendocrine Carcinoma of the SkinStage III Neuroendocrine Carcinoma of the SkinStage IV Neuroendocrine Carcinoma of the Skin
Worked with same sponsors:
National Cancer Institute (NCI)
Similarity Score18%
Julian R. Molina, M.D., Ph.D.
Mayo Clinic
1 trials
Shared therapeutic areas:
Recurrent Neuroendocrine Carcinoma of the SkinStage III Neuroendocrine Carcinoma of the Skin
Similarity Score12%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Oblimersen in Treating Patients With Merkel Cell Carcinoma
Recurrent Neuroendocrine Carcinoma of the SkinStage I Neuroendocrine Carcinoma of the SkinStage II Neuroendocrine Carcinoma of the Skin+2 more
All 1 trials loaded